How We Lead – Perspectives from Two Key Biotechnology Hubs in North America

March 8, 2021 11:30 AM - 1:15 PM

Webinar, click "live-stream" button to view

Add to Calendar 3/8/2021 11:30:00 AM 3/8/2021 1:15:00 PM How We Lead – Perspectives from Two Key Biotechnology Hubs in North America

Join us on International Women’s Day, March 8, 2021, when WIB-Greater Montreal and WIB-Greater Boston will present a joint event with BIOQuébec and MassBio.

BIOQuébec is committed to supporting Québec’s biotechnology and life sciences industry. MassBio’s mission is to advance Massachusetts’ leadership in the life sciences and each is dedicated to improving healthcare and quality of life. Join the discussion of the landscape in Quebec and Massachusetts and biotech leaders’ perspectives on challenges/obstacles faced, leadership styles, where do we want to be, and how do we get there.

The event will be facilitated by journalist-columnist Tasha Kheiriddin with panelists from Québec: Anie Perrault, executive director BIOQuébec, Clarissa Desjardins, founder and former CEO, Clementia (now Ipsen), and Nadine Beauger, President & CEO, IRICOR and from Massachusetts: Kendalle Burin O’Connell, President & COO MassBio, Ramani Varanasi- President & CEO of X-Biotix Therapeutics, and Liang Schweizer- CEO & CSO of HiFiBiO Therapeutics.

PLEASE NOTE: You will be redirected to the Women In Bio event page by clicking, "Register Now." This event requires you to sign-in to receive a personalized link to the webinar. Please select “sign-in” and then choose “non-member.” The event is free for all MassBio members.

Disclaimer: This event may be recorded. There is a possibility your image and/or voice may be a part of that recording. If you are uncomfortable, please be sure to turn off your webcam.

 Webinar, click "live-stream" button to view
CEO & President | MassBio
As CEO and President of MassBio, Kendalle Burlin O’Connell leads the strategic direction for the organization and drives policy advocacy for the industry to ensure that Massachusetts life sciences companies have the best environment possible to research, develop, manufacture, and commercialize breakthrough therapies and cures for people around the world. Pursuing innovation and delivering for members are the hallmarks of Kendalle’s more than 16 years at MassBio, including the launch of several multi-year initiatives focused on realizing a diverse and equitable life sciences industry, supporting the continued growth and sustainability of the industry throughout Massachusetts, and providing resources and solutions to companies across the industry value chain. In 2023, she was the driving force behind MassBio’s launch of Bioversity, a non-profit created to develop new training pathways and create employer connections for underrepresented populations and individuals traditionally left out of the life sciences, starting with a workforce training center in Dorchester featuring industry-aligned certification and upskilling programs. Kendalle has earned wide acclaim for her leadership and is active in mentoring and professional organizations. She has earned a spot on the Boston Business Journal’s 2023 Power 50: Movement Makers list, is ranked number 33 on Boston Magazine’s 2023 list of The 150 Most Influential Bostonians, a 2022 recipient of the Cambridge Chamber of Commerce Inspire Award recognizing outstanding women leaders in the Cambridge community, a 2022 Boston power player as named by Axios, a 2021 executive fellow in the inaugural class of the Civic Action Project Collaborative, and a 2019 Boston Business Journal 40 under 40 honoree which acknowledges a leader’s impact on Massachusetts’ industries. Kendalle received her Juris Doctor from Suffolk University Law School and currently serves as a Director on the Board of The Boston Foundation and Vice Chair of the Eastern New England Board of Directors for the American Cancer Society.